Scarica l'app Stockscreener
146.39
0.36%
-0.48
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Precedente Chiudi:
$146.87
Aprire:
$146.87
Volume 24 ore:
66,510
Relative Volume:
0.04
Capitalizzazione di mercato:
$10.14B
Reddito:
$2.90B
Utile/perdita netta:
$302.80M
Rapporto P/E:
34.07
EPS:
4.2965
Flusso di cassa netto:
$387.80M
1 W Prestazione:
+2.10%
1M Prestazione:
-10.61%
6M Prestazione:
-39.50%
1 anno Prestazione:
-55.36%
Intervallo 1D:
$145.03
$147.72
Intervallo di 1 settimana:
$138.28
$155.17
Portata 52W:
$126.40
$354.88
Insulet Corp Stock (PODD) Company Profile
Nome
Insulet Corp
Settore
Industria
Telefono
978-600-7000
Indirizzo
100 NAGOG PARK, ACTON, MA
Compare PODD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corp
|
146.27 | 10.51B | 2.90B | 302.80M | 387.80M | 4.2965 |
ABT
Abbott Laboratories
|
114.75 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.92 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.36 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.54 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Insulet Corp Stock (PODD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-24 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| 2026-04-07 | Downgrade | Citigroup | Buy → Neutral |
| 2026-01-27 | Ripresa | TD Cowen | Hold |
| 2026-01-12 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-16 | Iniziato | Evercore ISI | Outperform |
| 2025-11-19 | Aggiornamento | UBS | Neutral → Buy |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Ripresa | Oppenheimer | Outperform |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-05-13 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-04-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2025-03-06 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-11-06 | Iniziato | Bernstein | Outperform |
| 2024-05-30 | Iniziato | Redburn Atlantic | Buy |
| 2024-05-07 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-08-21 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-08-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-01-26 | Iniziato | Wolfe Research | Peer Perform |
| 2022-11-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-02-02 | Aggiornamento | UBS | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-01 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | Downgrade | Citigroup | Buy → Neutral |
| 2020-07-28 | Iniziato | Wells Fargo | Overweight |
| 2020-04-24 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | Iniziato | BofA/Merrill | Neutral |
| 2020-03-31 | Downgrade | Berenberg | Buy → Hold |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-12-10 | Iniziato | CFRA | Sell |
| 2019-10-23 | Iniziato | Stifel | Hold |
| 2019-10-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2019-10-04 | Downgrade | UBS | Buy → Neutral |
| 2019-10-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-08-06 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-06-10 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2018-04-20 | Iniziato | Berenberg | Buy |
| 2018-02-22 | Reiterato | Barclays | Overweight |
| 2018-01-08 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | Iniziato | Barclays | Overweight |
Mostra tutto
Insulet Corp Borsa (PODD) Ultime notizie
Mitsubishi UFJ Asset Management Co. Ltd. Makes New Investment in Insulet Corporation $PODD - MarketBeat
Deutsche Bank AG Purchases Shares of 335,980 Insulet Corporation $PODD - MarketBeat
PODD INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - The AI Journal
Insulet Corp (PODD) Shares Fall 3.0% -- What GF Score of 81 Tells Investors - GuruFocus
Insulet Corp. stock underperforms Thursday when compared to competitors - MarketWatch
PODD UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
14,672 Shares in Insulet Corporation $PODD Purchased by Aurora Investment Counsel - MarketBeat
Insulet Corporation Stockholders May Be Eligible to Lead the Class Action Against PODD; Contact Robbins LLP Before the August 31, 2026 Deadline for Information - The Globe and Mail
Is It Too Late to Buy Insulet Corp (PODD) After 6.0% Rally? GF V - GuruFocus
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet (NASDAQ:PODD) Shares Up 4.9%What's Next? - MarketBeat
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026 - TMX Newsfile
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD) - TMX Newsfile
Attention Long-Term Shareholders of ARS Pharmaceuticals, - GlobeNewswire
AUGUST 31, 2026 INVESTOR DEADLINE: Insulet Corporation - GlobeNewswire
2 WEEK INVESTOR DEADLINE: Insulet Corporation Investors with Substantial Losses Have Opportunity to Lead the Insulet Class Action Lawsuit Before August 31, 2026 DeadlinePODD - PR Newswire
Insulet Corp. stock underperforms Monday when compared to competitors - MarketWatch
Why Insulet (PODD) Stock Is Down Today - Quiver Quantitative
Insulet (PODD) Q2 2026 Earnings Call Transcript - AOL.com
OneDigital Investment Advisors LLC Buys Shares of 44,275 Insulet Corporation $PODD - MarketBeat
GSA Capital Partners LLP Acquires New Holdings in Insulet Corporation $PODD - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
PODD FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Insulet Corporation ... - Caledonian Record
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call - Yahoo Finance
PODD IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Insulet Corporation ... - Caledonian Record
Contact Robbins LLP for Information About Leading the Lawsuit That Alleges Insulet Corporation ... - Caledonian Record
Important Notice to Long-Term Shareholders of Bloom Energy - GlobeNewswire
Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier - Yahoo Finance
Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit - PR Newswire
Insulet Corporation (PODD) Stock Forecasts - Yahoo Finance
Insulet hires Pfizer alum Joan Campion to lead external comms - Medical Marketing and Media
PODD CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (P - The National Law Review
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Important Notice to Long-Term Shareholders of Erasca, Inc. - GlobeNewswire
Insulet Corporation (NASDAQ:PODD) Given Average Rating of "Hold" by Brokerages - MarketBeat
Insulet Corporation $PODD Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Insulet Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Bank of America Corp DE Sells 61,769 Shares of Insulet Corporation $PODD - marketbeat.com
Insulet (NASDAQ:PODD) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Beacon Investment Advisory Services Inc. Has $9.03 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
PODD SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Insulet (PO - The National Law Review
PODD INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds - The National Law Review
PODD SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds In - The National Law Review
Insulet Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
PODD Maintained by TD Cowen -- Price Target Lowered to $144 - GuruFocus
Insulet (PODD) Stock Looks Undervalued As The Market Stays Cautious - Yahoo Finance
Insulet (NASDAQ:PODD) Price Target Lowered to $144.00 at TD Cowen - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $150.00 at UBS Group - MarketBeat
Insulet (NASDAQ:PODD) Given New $185.00 Price Target at Benchmark - MarketBeat
Insulet (NASDAQ:PODD) Price Target Lowered to $180.00 at Stifel Nicolaus - MarketBeat
Insulet Corp Azioni (PODD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):